T2R-23161-12457
3 vaccinations
4 coded responses
38 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 496 / MI
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3NQ-22588-86173
Child or adolescent in my care · Female · 2021-09-29
2RN-98567-86417
Child or adolescent in my care · Male · 2021-11-09
6E8-60382-40612
Child or adolescent in my care · Male · 2021-11-09
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
-
2021-10-05
Survey response — day 7, dose 3MedDRA: Ear pain — Feeling: GoodFree text: Ear acheMedDRA releases: 2024-11 · check-in free text available
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
-
2021-12-28
Survey response — 3 months, dose 3MedDRA: Ear pain, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion/sore throat/ear acheMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-30
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-03-29
Survey response — 6 months, dose 3MedDRA: Cough, Fatigue, Headache, Pain, SARS-CoV-2 test positive, Sinus congestion, Throat irritation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I came down with body aches/headache, scratchy throat and mild cough, and eventually sinus congestion, along with fatigue. The symptoms were relatively mild, but I did eventually test positive for COVID. Most symptoms resolved, except lingering coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-28
Survey response — 12 months, dose 3MedDRA: COVID-19, Chills, Cough, Headache, Hyperhidrosis, Myalgia, Oropharyngeal pain, Pain, Pain in extremity, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had Covid March 2022 included soreness, muscle aches, headache, fever/chills, sore throat, lingering cough. Had new bivalent booster last week- muscle aches, fever/sweats, headache, arm soreness for 1-2 daysMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — day 7, dose 3
Systemic reaction (other): Ear ache
Release 10 — 3 months, dose 3
Symptoms: Congestion/sore throat/ear ache
Release 11 — 6 months, dose 3
Symptoms: I came down with body aches/headache, scratchy throat and mild cough, and eventually sinus congestion, along with fatigue. The symptoms were relatively mild, but I did eventually test positive for COVID. Most symptoms resolved, except lingering cough cut off by CDC
Release 12 — 12 months, dose 3
Symptoms: Had Covid March 2022 included soreness, muscle aches, headache, fever/chills, sore throat, lingering cough. Had new bivalent booster last week- muscle aches, fever/sweats, headache, arm soreness for 1-2 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Ear pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release